Market revenue in 2020 | USD 319.2 million |
Market revenue in 2028 | USD 674.3 million |
Growth rate | 9.8% (CAGR from 2020 to 2028) |
Largest segment | Reagents |
Fastest growing segment | Reagents |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 57.46% in 2020. Horizon Databook has segmented the Japan infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2028.
The infectious diseases molecular diagnostics market in Japan is estimated to exhibit a CAGR of 9.8% during the forecast period owing to presence of wellestablished public healthcare system and proactive government healthcare initiatives.
These factors have made significant contribution to low mortality rate due to infectious diseases. Furthermore, high prevalence of target diseases, rise in awareness, and high geriatric population, which is susceptible to infectious diseases are other factors driving growth.
Infectious diseases with highest mortality rate in Japan are influenza, infectious gastroenteritis, Tuberculosis (TB), and MRSA infections. Strategies being undertaken for geographic expansion in Asia Pacific by major U.S.-based players, to strengthen their position, are anticipated to drive the Japanese market.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan infectious disease molecular diagnostics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account